BioSpace News Archive

Takara Bio USA, Inc. is proud to announce that researchers at the University of Helsinki, Universidade Católica Portuguesa, CBQF, and Technische Universität Dresden, Institute of Hydrobiology, along with other collaborators have performed the first trans-Europe surveillance study on antibiotic resistance utilizing the SmartChip Real-Time PCR System.

Research that has redefined the trajectory and true impact of the disease underscores the campaign

Emily Leproust, Ph.D., CEO and co-founder, will present at the UBS Global Healthcare Conference on Monday, May 20th at 11:30 a.m. ET.

Takeda Pharmaceutical Company Limited and the London School of Hygiene & Tropical Medicine will announce at the evening reception, hosted by the Embassy of Japan in the United Kingdom, the establishment of the Takeda Chair in Global Child Health, endowed by a £3 million donation by Takeda to LSHTM.

Medivir AB today informs that new data from the phase I study of birinapant in combination with pembrolizumab (Keytruda®) will be presented during the American Society of Clinical Oncology annual meeting, which will take place 31 May – 04 June in Chicago, USA.

Oversubscribed round led by LSP will fund accelerated product development and commercial operations in the U.S.

Intec Pharma Ltd. announces it has entered into an agreement with Merck, known as MSD outside the United States and Canada, to explore using the Accordion Pill® platform for an undisclosed development program.

Insulet Corporation, the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, announced that management will present at two upcoming investor conferences

ViewRay, Inc. announced that the Company will participate in the Jefferies 2019 Global Healthcare Conference in New York, New York.

Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that GSK has expanded its 2016 licensing and collaboration agreement with Zymeworks for the research, development, and commercialization of bispecific antibodies across multiple disease areas.